Credit Suisse’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$48.7M Sell
1,420,633
-2,901
-0.2% -$105K 0.05% 380
2023
Q4
$52.5M Sell
1,423,534
-152,796
-10% -$3.53M 0.05% 373
2023
Q3
$31.9M Buy
1,576,330
+111,521
+8% +$2.45M 0.03% 507
2023
Q2
$30M Buy
1,464,809
+17,501
+1% +$262K 0.03% 550
2023
Q1
$21.8M Buy
1,447,308
+30,968
+2% +$684K 0.02% 646
2022
Q4
$33.7M Sell
1,416,340
-260
-0% -$7.54K 0.04% 516
2022
Q3
$49.9M Buy
1,416,600
+278
+0% +$11.8K 0.06% 371
2022
Q2
$49.5M Buy
1,416,322
+1,830
+0.1% +$64.8K 0.05% 389
2022
Q1
$69.8M Sell
1,414,492
-29
-0% -$1.61K 0.06% 341
2021
Q4
$109M Sell
1,414,521
-20,265
-1% -$2.08M 0.06% 335
2021
Q3
$153M Buy
1,434,786
+10,399
+0.7% +$1.19M 0.08% 237
2021
Q2
$190M Buy
1,424,387
+64,179
+5% +$7.46M 0.1% 196
2021
Q1
$168M Buy
1,360,208
+513,627
+61% +$78M 0.09% 251
2020
Q4
$120M Buy
846,581
+800,661
+1,744% +$88.8M 0.06% 350
2020
Q3
$3.49M Sell
45,920
-33,841
-42% -$2.11M ﹤0.01% 2030
2020
Q2
$3.61M Buy
79,761
+50,006
+168% +$1.79M ﹤0.01% 1927
2020
Q1
$910K Sell
29,755
-114
-0.4% -$3.06K ﹤0.01% 2721
2019
Q4
$628K Buy
29,869
+17,173
+135% +$402K ﹤0.01% 3430
2019
Q3
$303K Buy
+12,696
New +$369K ﹤0.01% 3693

Other funds holding TWST

Credit Suisse's TWST Position: Q1 2024 in Review

Credit Suisse reduced its Twist Bioscience (TWST) stake by 0.2% in Q1 2024, selling an estimated $105K and leaving 1,420,633 shares worth $48.7M. The position accounts for 0.05% of the portfolio, ranked #380.

Credit Suisse first reported a position in TWST in Q3 2019 and has held it in 19 quarters since. The position peaked at $190M in Q2 2021. 237 funds tracked by Wall St. Rank hold TWST as of Q1 2024.

  • Credit Suisse held 1,420,633 shares of Twist Bioscience worth $48.7M as of Q1 2024.
  • Credit Suisse sold 2,901 Twist Bioscience shares in Q1 2024, an estimated $105K.
  • Twist Bioscience made up 0.05% of Credit Suisse's portfolio in Q1 2024, its #380 holding.
  • Credit Suisse first reported a position in Twist Bioscience in Q3 2019 and has held it in 19 quarters since.
  • Credit Suisse's Twist Bioscience position peaked at $190M in Q2 2021.
  • 237 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.